This inventor holds 2 USPTO granted patents. Top assignees: Universität Autonoma De Barcelona, Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncologicas Carlos III (f.s.p. Cnio), Fundación Del Sector Público Estatal Centro Nacional Dl'investigaciones Oncológicas Carlos III (f.s.p. Cnio). Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 49 
1 out of 4 
1 out of 1 Years Active: 2022
Title: Christian Baer: Innovator in Telomerase Therapies
Introduction
Christian Baer is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of therapies related to telomerase reverse transcriptase. With a total of 2 patents, Baer is recognized for his innovative approaches to addressing critical health conditions.
Latest Patents
Baer's latest patents focus on telomerase reverse transcriptase-based therapies. The first invention provides compositions and methods useful for the treatment and prevention of conditions associated with short telomere length. The second patent addresses therapies for the treatment of conditions associated with myocardial infarction, offering compositions and methods that aim to improve patient outcomes in this critical area.
Career Highlights
Throughout his career, Christian Baer has worked with esteemed organizations such as the National Center for Cancer Research (CNIO) and the Autonomous University of Barcelona. His work in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Baer has collaborated with notable colleagues, including Maria Antonia Blasco Marhuenda and Fàtima Bosch I Tubert. These partnerships have enriched his research and fostered innovation in the field of biotechnology.
Conclusion
Christian Baer stands out as an influential inventor in the realm of telomerase therapies. His contributions continue to pave the way for advancements in medical treatments and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile